Surgical complications and implant survival of the Osseointegrated Prostheses for the Rehabilitation of Amputees system in patients with combat-related limb loss: a retrospective cohort study.
Stanislav Bondarenko, Oleksandr Haluzynskyi, Valentyna Maltseva, Oleksandr Linenko, Mykhailo Rudas
{"title":"Surgical complications and implant survival of the Osseointegrated Prostheses for the Rehabilitation of Amputees system in patients with combat-related limb loss: a retrospective cohort study.","authors":"Stanislav Bondarenko, Oleksandr Haluzynskyi, Valentyna Maltseva, Oleksandr Linenko, Mykhailo Rudas","doi":"10.1007/s00264-026-07054-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess implant survival, postoperative complications, and infection-related risk factors in veteran amputees treated with a bone-anchored prosthetic system.</p><p><strong>Methods: </strong>This retrospective study analysed clinical data from 49 veterans of the Russo-Ukrainian war who underwent implantation of the Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) system for upper or lower limb amputation in 2023-2024. Implant survival and complication rates were analysed at one-year follow-up after the second surgical stage (S2).</p><p><strong>Results: </strong>The first stage of OPRA was performed in 49 patients (51 implants): 21 transfemoral, 27 transhumeral, and transtibial. Three patients declined S2, and one humeral implant was explanted after S1. The S2 was completed in 45 patients (47 implants). At one-year follow-up after S2, implant survival was 97.9% with one of 47 implants explanted because of septic loosening. Infectious complications occurred in 18% of patients, including Grade 4 infection in 2%. Beyond one year (median follow-up, 18.7 months), two additional implants were explanted (periprosthetic fracture, n = 1; septic loosening, n = 1).</p><p><strong>Conclusion: </strong>OPRA implantation in veteran amputees demonstrated favourable short-term implant survival (97.9% at one-year follow-up after S2), although longer-term follow-up is required.</p>","PeriodicalId":14450,"journal":{"name":"International Orthopaedics","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2026-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Orthopaedics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00264-026-07054-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To assess implant survival, postoperative complications, and infection-related risk factors in veteran amputees treated with a bone-anchored prosthetic system.
Methods: This retrospective study analysed clinical data from 49 veterans of the Russo-Ukrainian war who underwent implantation of the Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) system for upper or lower limb amputation in 2023-2024. Implant survival and complication rates were analysed at one-year follow-up after the second surgical stage (S2).
Results: The first stage of OPRA was performed in 49 patients (51 implants): 21 transfemoral, 27 transhumeral, and transtibial. Three patients declined S2, and one humeral implant was explanted after S1. The S2 was completed in 45 patients (47 implants). At one-year follow-up after S2, implant survival was 97.9% with one of 47 implants explanted because of septic loosening. Infectious complications occurred in 18% of patients, including Grade 4 infection in 2%. Beyond one year (median follow-up, 18.7 months), two additional implants were explanted (periprosthetic fracture, n = 1; septic loosening, n = 1).
Conclusion: OPRA implantation in veteran amputees demonstrated favourable short-term implant survival (97.9% at one-year follow-up after S2), although longer-term follow-up is required.
期刊介绍：
International Orthopaedics, the Official Journal of the Société Internationale de Chirurgie Orthopédique et de Traumatologie (SICOT) , publishes original papers from all over the world. The articles deal with clinical orthopaedic surgery or basic research directly connected with orthopaedic surgery. International Orthopaedics will also link all the members of SICOT by means of an insert that will be concerned with SICOT matters.
Finally, it is expected that news and information regarding all aspects of orthopaedic surgery, including meetings, panels, instructional courses, etc. will be brought to the attention of the readers.
Manuscripts submitted for publication must contain a statement to the effect that all human studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.
Reports of animal experiments must state that the "Principles of laboratory animal care" (NIH publication No. 85-23, revised 1985) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable.
The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfil the above-mentioned requirements.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
